Загрузка...
Serotonin syndrome by drug interactions with linezolid: clues from pharmacovigilance-pharmacokinetic/pharmacodynamic analysis
PURPOSE: To characterize the post-marketing reporting of serotonin syndrome (SS) due to drug-drug interactions (DDIs) with linezolid and investigate the relationship with pharmacokinetic/pharmacodynamic (PK/PD) properties of serotonergic agents. METHODS: We queried the worldwide FDA Adverse Event Re...
Сохранить в:
| Опубликовано в: : | Eur J Clin Pharmacol |
|---|---|
| Главные авторы: | , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Springer Berlin Heidelberg
2020
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7803711/ https://ncbi.nlm.nih.gov/pubmed/32901348 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00228-020-02990-1 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|